The Tisch Cancer Institute
@TischCancer
Followers
4K
Following
2K
Media
2K
Statuses
7K
Committed to cancer prevention, detection, treatment & research. Cancer center for @MountSinaiNYC & @IcahnMountSinai. Appointments: 1-844-MD CANCER
New York, NY
Joined June 2014
Short-Interval HPV Retesting Shows Triage Promise for Cervical Cancer Screening https://t.co/Nfwh3rvGo9
@StephanieVBlank weighs in #cervicalcancer
medpagetoday.com
Good sensitivity for high-risk cervical neoplasia, but cost-effectiveness studies needed
0
0
0
.@jsparano, @IcahnMountSinai, is presenting at @gotoPER School of Breast Oncology, Nov 6-8 “Considerations in Systemic Therapy for Early-Stage Triple Negative Breast Cancer” “The Art and Science of Managing HER2-Negative Metastatic Breast Cancer” #BreastCancerAwarenessMonth
1
0
3
Hanna Irie, MD, PhD, and colleagues report in @CellCellPress: A PROTAC degrader suppresses oncogenic functions of PTK6, inducing apoptosis of breast cancer cells https://t.co/CkUE9Yylnv
#BreastCancerAwarenessMonth
@IcahnMountSinai Jian Jin, PhD; @DrElisaPort
0
0
0
This Breast Cancer AwarenessMonth, take time for you 🩷 A mammogram could save your life, early detection makes all the difference. Schedule yours today. 🎀 https://t.co/sqOOsvvSAj
#BreastCancerAwarenessMonth
0
1
1
🎀Mount Sinai’s Mammovan hits the road to bring screening access to every borough. #BreastCancerAwareness
amny.com
Mount Sinai’s Mobile Mammography Program is hitting NYC with it's mobile screening vehicle, the Mammovan.
0
2
2
Terrified/excited to present new history of med work @HMSCountway 10/9 and @SchulichMedDent 10/16 on how a FL mental health law passed to protect civil rights of mentally ill pts forever linked child mental health to law enforcement. Join me on zoom!
1
1
2
Dr. Fred Hirsch highlights how knowledge of the molecular characteristics of non-small cell lung cancer enhances understanding of the disease. https://t.co/it5kxUmgqA
@fred_hirsch @IcahnMountSinai #lungcancer
curetoday.com
Dr. Fred Hirsch highlighted how knowledge of the molecular characteristics of non-small cell lung cancer enhances understanding of the disease.
0
0
0
Missed mammograms increase chances of advanced cancer, study finds. https://t.co/0nJsJbiMEu via @CBSNews
@MargoliesLaurie Dr. Laurie Margolies, Vice Chair of Breast Imaging @MountSinaiNYC explains the findings. #BreastCancerAwarenessMonth #BreastCancer #Mammogram
cbsnews.com
There's a new warning for women about the devastating costs of skipping regular mammograms. A new study finds women who miss their first breast cancer screening could have a 40% higher long-term risk...
0
0
0
We look forward to a presentation by Kathryn Lurain, MD, MPH, @OSUHematology, on Oct. 9. Immunomodulation for Virus-Associate Lymphomas
0
3
3
Landmark Merger Launches First Institute Dedicated to Aging and Cancer https://t.co/uQMhzTLLOn
@oncodaily
oncodaily.com
Landmark Merger Launches First Institute Dedicated to Aging and Cancer / aging and cancer, Headlines, Mark Foundation, Mark Foundation for Cancer Research,
1
1
1
The Lancet Commission on addressing the global hepatocellular carcinom... https://t.co/W7bdGEEGY8 Josep Llovet and Myron Schwartz with @IcahnMountSinai served on the commission, established to address the rising disease burden of hepatocellular carcinoma. #HCC
0
0
0
ctDNA Use in Bladder Cancer Care: Where Things Stand and Where They’re Headed https://t.co/SgdztFAPEI With Matt Galsky, MD, @IcahnMountSinai #bladdercancer
oncologynewscentral.com
Matthew Galsky, MD, discusses where things stand for the use of circulating tumor DNA in bladder cancer care, and where the field is likely heading.
0
0
0
John Mascarenhas, MD, outlines the ongoing phase 3 IMpact-MF trial, evaluating imetelstat in relapsed/refractory myelofibrosis. https://t.co/PWkvqgeQNc
@IcahnMountSinai #myelofibrosis
onclive.com
John Mascarenhas, MD, outlines the ongoing phase 3 IMpact-MF trial, evaluating imetelstat in relapsed/refractory myelofibrosis.
0
0
0
48th I-ELCAP / 16th IELCART Conferences October 9-11. Register at https://t.co/MMBRXW1pq6
#lungscancer #lungcancerscreening
@IcahnMountSinai
0
0
1
Study, published in the Sep/Oct 2025 issue of Practical Radiation Oncology, is the first to identify which aspects of spiritual history patients prioritize and find most meaningful. https://t.co/jpc45dZZ0l
@laurenjacobs_md @KarynAGoodman @IcahnMountSinai
0
3
4
Jill Martin and TODAY Champion Genetic Testing for Breast Cancer on the Plaza: 'Take Knowledge Into Your Own Hands' https://t.co/Pf8BV9SL9Z via @TODAYshow
@DrElisaPort @IcahnMountSinai provides expert insight. #BreastCancerAwarwnessMonth #BreastCancer #BRCA
today.com
TODAY contributor Jill Martin discovered she had breast cancer after taking a genetic test in 2023.
0
0
1
.@ovanoekelen discusses findings on the role of S100A8/A9 in promoting T-cell exhaustion and limiting responses to bispecific antibody therapy in #MultipleMyeloma
https://t.co/ndvjTszfo7
@IcahnMountSinai
onclive.com
Oliver Van Oekelen, MD, PhD, discusses how S100A8/A9 in promotes T-cell exhaustion and limits responses to bispecific antibody therapy in multiple myeloma.
0
0
1
Understanding Patient Priorities for Religious and Spiritual Needs During Radiation Therapy for Gynecological Malignancies - Practical Radiation Oncology https://t.co/7nyHZAlbYF
@laurenjacobs_md @KarynAGoodman @IcahnMountSinai #practicalRO #gynocology
0
2
5
CCR4-Directed Strategy Achieves Durable Response in T-Cell Lymphoma Following Treatment with Anti-BCMA CAR T-Cell Therapy @TischCancer @IcahnMountSinai #lymsm
https://t.co/wMxF6zhdnL
onclive.com
Samir Parekh, MD, discusses managing a rare T-cell lymphoma post BCMA CAR T-cell therapy and how CCR4-targeted treatment achieved durable remission.
0
4
5
Experience Real-World Practice Through Expert-Led Preceptorships. Focus on #lungcancer. @DDoroshow @IcahnMountSinai is on the faculty for this Halloween event. Chaired by Catherine Shu @ColumbiaMed. https://t.co/ubLzxr048Y
@OncLive
0
0
0